Ventilator-associated tracheobronchitis; the impact of targeted antibiotic therapy on patient outcomes

Chest

Volumn 135, Issue 2, 2009, Pages 521-528

  Craven, Donald E ^a,b   Chroneou, Alexandra ^b   Zias, Nikolaos ^b   Hjalmarson, Karin I ^a  

^a Departments of Infectious Diseases   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Aerosolized antibiotics; Antibiotic therapy; Methicillin resistant staphylococcus aureus; Morbidity and mortality; Prevention; Pseudomonas aeruginosa; Ventilator associated pneumonia; Ventilator associated tracheobronchitis

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CIPROFLOXACIN; GENTAMICIN; PLACEBO; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG TARGETING; ENDOTRACHEAL TUBE; FEVER; GRAM STAINING; HOST RESISTANCE; HUMAN; INFECTION RISK; LEUKOCYTE; LEUKOCYTOSIS; LOWER RESPIRATORY TRACT; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPUTUM; SPUTUM CULTURE; THORAX RADIOGRAPHY; TRACHEA; TRACHEAL ASPIRATION PROCEDURE; TRACHEOBRONCHITIS; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS;

EID: 60249102733     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1617     Document Type: Article

References (36)

1. Niederman MS, Craven DE, Bonten MJ. American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA): guideline for the management ofadults with hospital- acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
2. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled multicenter study. Crit Care 2008; 12:R62
3. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008 -2013
4. Torres A, Valencia M. Does ventilator-associated tracheobronchitis need antibiotic treatment? Crit Care 2005; 9:255-256
5. Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002; 20:1483-1489
6. Kampf G, Wischnewski N, Schulgen G, et al. Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals. J Clin Epidemiol 1998; 51:495-502
7. Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients: influence of level of consciousness with implications for therapy. Chest 1992; 102:525-529
8. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003; 31:1964-1970
9. Craven DE. Ventilator-associated tracheobronchitis (VAT): questions, answers and a new paradigm? Crit Care 2008; 12:157
10. Luyt CE, Combes A, Deback C, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175:935-942
11. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
12. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121
13. Jia X, Malhotra A, Saeed M, et al. Risk factors for ARDS in patients receiving mechanical ventilation for > 48 h. Chest 2008; 133:853-861
14. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006; 130:251-260
15. El Solh AA, Akinnusi ME, Wiener-Kronish JP, et al. Persistent infection with Pseudomonas aeruginosa in ventilator associated pneumonia. Am J Respir Crit Care Med 2008; 178:513-519
16. Foster TJ. The Staphylococcus aureus "superbug." J Clin Invest 2004; 114:1693-1696
17. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53:1-36
18. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-281
19. Luyt CE, Guerin V, Combes A, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171:48-53
20. Rea-Neto A, Youssef NC, Tuche F, et al. Diagnosis of ventilator- associated pneumonia: a systematic review of the literature. Crit Care 2008; 12:R56
21. Lisboa T, Craven D, Rello J. Safety in critical care and pulmonary medicine: should VAP be a quality indicator for patient safety? Clin Pulm Med 2008 (in press)
22. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005; 25:804-812
23. Basi SK, Marrie TJ, Huang JQ, et al. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004; 117:305-311
24. Klompas M. Does this patient have ventilator-associated pneumonia? JAMA 2007; 297:1583-1593
25. Klompas M, Kulldorff M, Platt R. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 2008; 46:1443-1446
26. Graat ME, Choi G, Wolthuis EK, et al. The clinical value of daily routine chest radiographs in a mixed medical-surgical intensive care unit is low. Crit Care 2006; 10:R11
27. Syrjala H, Broas M, Suramo I, et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998; 27:358-363
28. Winer-Muram HT, Rubin SA, Ellis JV, et al. Pneumonia and ARDS in patients receiving mechanical ventilation: diagnostic accuracy of chest radiography. Radiology 1993; 188:479-485
29. A'Court CH, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 1993; 86:635-648
30. Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14:1015-1022
31. Nseir S, Di Pompeo C, Soubrier S, et al. Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: a case-control study. Infection 2004; 32:210-216
32. Nseir S, Ader F, Marquette CH, et al. Impact of fluoroquin- olone use on multidrug-resistant bacteria emergence [in French]. Pathol Biol (Paris) 2005; 53:470-475
33. Liberati A, D'Amico R, Pifferi, et al. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev 2004; CD000022
34. Tantipong H, Morkchareonpong C, Jaiyindee S, et al. Randomized controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008; 29:131-136
35. Craven DE. What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis 2006; 19:153-160
36. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511